Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03566732
Other study ID # ELAC2015/T07-0545
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 15, 2017
Est. completion date December 7, 2018

Study information

Verified date August 2023
Source University of Bergen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Providing high quality care for dying patients and their families is very important. One way one can assess the care provided is to ask bereaved relatives to complete a questionnaire after their family member has died. The questionnaire can ask about their experiences and their thoughts about the care provided to their family member. One such questionnaire is the 'Care Of the Dying Evaluation' (or CODE). CODE has been developed with the help and support of bereaved relatives and has been used extensively within the United Kingdom. In this project the investigators want to use the CODE questionnaire to look at bereaved relatives' views about care provided in seven different countries within Europe and Latin America. In the first part of the project CODE was translated into the main language of each country. Volunteers and bereaved relatives in each country were asked to give feedback about whether CODE was easy to understand, sensitive, and easy to complete. Based on the feedback a common version of CODE that is suitable for use across all the countries was developed. In the next phase of the project, relatives who have recently experienced a bereavement where one of their family members has died from cancer in a hospital, will be invited to complete the CODE questionnaire about two months after the patient's death. The relatives may complete CODE on paper, using a computer, or by interview. The aim is to have 100 completed CODE questionnaires from each of the seven countries. The data from the questionnaires will be used to make a report on the current quality of care for dying cancer patients in hospitals across the seven countries. It will also be possible to compare the care between the countries and identify areas needing improvement. In the next phase of the project, health care professionals, researchers and bereaved relatives together will use their knowledge and experience to find effective ways to improve the weak areas identified, and assess the results of putting these changes into practice.


Description:

ABSTRACT Background: In order to ensure the highest quality of care is provided for dying patients and their families, one needs to first be able to robustly evaluate the current quality of care. One identified method is to assess this from the user-perspective by conducting bereaved relatives' surveys. 'Care Of the Dying Evaluation' (CODE) is a recognised, validated post-bereavement questionnaire which has been extensively used within the United Kingdom. The ERANet-LAC CODE project aims to use CODE in a wider international context. In Work Package 1 of the project, CODE will be translated and pilot tested in volunteers and bereaved relatives in the partner countries. Using a consensus procedure, a final version of the international CODE (i-CODE) questionnaire will be developed. Aims: The present project (Work Package 2) aims to advance the international evidence in care for dying cancer patients by undertaking an observational study of bereaved relatives' views across seven participating countries. The overall aims of Work Package 2 (WP2) are to: - Conduct an international survey of bereaved relatives of cancer patients dying in hospitals, using the CODE questionnaire - Use the CODE data to provide feedback about the quality of care and level of family support at an international and national level, allowing for cross-country comparisons - Conduct a web survey of all participating institutions to be able to interpret the survey data in the context of information about each organisation and the level of specialist palliative care provision at each site / country Methods: Bereaved adult relatives, to adult cancer patients who had an 'expected' death in hospital, will be approached face to face, by telephone or in writing and invited to complete the CODE questionnaire. The CODE questionnaire pack will be sent out 6-8 weeks after bereavement. CODE may be completed via self-completion paper questionnaire, via on-line questionnaire, or facilitated via a researcher using a tablet, telephone or face-to-face interview, according to what is feasible and acceptable in each country. The aim is 100 completed questionnaires per country. Basic demographics will be recorded for all potential participants and for the patients who died. Analysis of results: Data will be analysed using SPSS and according to the CODE user guide, to present a common international report, individual country reports and cross-country comparisons. Data will be interpreted in the context of knowledge about the individual sites/countries. Conclusions: The expected outcomes from WP2 are an international survey and cross-country comparisons about the current quality of care for dying cancer patients as perceived by bereaved people, including key areas where care needs to be improved. WP3 of the project will use the results of the international survey to implement changes to improve the care. INTRODUCTION The present project was proposed in response to the ERANet-LAC 2nd Joint Call on Research and Innovation and approved for funding under the European Commission's 7th framework program. The aim of the project is to inform and develop an evidence based approach to systematically standardize assessment and care of dying cancer patients, using relative generated outcomes. The project will be conducted in four European and three South American countries three years starting from January 2017. The project contains three Work Packages (parts). This protocol describes the work to be undertaken in Work Package 2 (CODE International Survey). BACKGROUND The delivery of appropriate care for dying cancer patients remains a key medical, social, economic and political issue. However, the quality of care for the dying is diverse both within and between EU-LAC countries. Based on the international evidence base, a set of core principles for care of the dying has been defined. These principles are applicable to the care of dying cancer patients, as well as other patients, worldwide. In order to ensure the highest quality of care provisions, one needs to first be able to robustly evaluate the current quality of care. One method is to assess this from the user-perspective by conducting bereaved relatives' surveys. 'Care Of the Dying Evaluation' Questionnaire One post-bereavement questionnaire is 'Care Of the Dying Evaluation' (CODE). This is a 42-item self-completion questionnaire, developed within the UK, and focused on the quality of care and the level of support provided to individuals and their families in the last days of life and the immediate post-bereavement period. CODE has been used and validated with bereaved relatives, including undertaking cognitive 'think aloud' interviews to assess face and content validity; assessing CODE's stability over time by conducting test-retest reliability analysis; and assessing the construct validity and internal consistency of CODE. Subsequently, CODE has been used across hospices, hospitals and community settings. In Work Package 1 of the present project, CODE was translated from English into the main language of each partner country according to established international procedures, and pilot tested in volunteers and bereaved relatives to assure understanding and appropriate cultural adaptation. Based on feedback from the testing in each country, a common, international version of CODE (iCODE) has been established through a consensus procedure. AIMS & OBJECTIVES The present project (Work Package 2) aims to advance the international evidence in care for dying patients by undertaking an observational study of bereaved relatives' views across seven participating countries, by use of the CODE questionnaire. The overall aims of Work Package 2 (WP2) are: - Conduct an international survey of bereaved relatives of cancer patients dying in hospitals, using the CODE questionnaire - Conduct a web survey of all participating institutions to aid in the interpretation of the survey data - Use the CODE data to provide feedback about the quality of care and level of family support at an international and national level, allowing for cross-country comparisons METHODS Study sites The necessary number of hospitals caring for adult cancer patients will be recruited as study sites. The study will only be performed in institutions defined as hospitals Recruitment The relative / next-of-kin must be approached after the patient's death. The investigators will approach the person recorded as next-of-kin in the patient's hospital record. Only one completed questionnaire will be included per deceased patient. Recruitment will be done prospectively. The method of recruitment will be adapted as to what is feasible and in the individual country. DATA COLLECTION CODE International Survey Data to be collected The CODE questionnaire is the common data collection tool of the study. CODE also includes demographic data. Information about the hospital stay will be included for all cases, as part of the inclusion procedure. Method of data collection The CODE questionnaire will be sent to the participants 6-8 weeks post bereavement, with on reminder. CODE International Survey was intended as a postal survey, but other data collection methods will also be accepted. Sample estimation: Minimum acceptable number of questionnaires per country is 100 (with this number, a 95% confidence interval will give a margin of error of +/- 10% of the primary outcome). Data transfer The electronic version and database for CODE for each country/language will be developed in Norway using the Corporate Surveyor software. The databases will be merged in Norway for the final common analyses. A web survey of study sites will also be conducted. DATA ANALYSIS Data will be analysed using the R statistical package, using descriptive statistics (proportions (%) for categorical data; means and standard deviations for continuous parametric data and medians and interquartile range for continuous non-parametric data). The dataset, anonymised at patient, site and country level, will be aggregated at international level to enable an international report. Results will be summarised in tabular and graphical format, as appropriate. Free text comments will be analysed using qualitative methods (text condensation). PROJECT MANAGEMENT AND WORK PLAN All partners have signed the consortium agreement. The PIs are responsible for the CODE international survey in their respective countries. The group of PIs constitute the project General Assembly and decision-making body. WP1 (Preparation and Piloting) ran from month 1 to month 7 of the project, i.e. from January to August 2017. WP2 is designed to run from month 8 to month 22 of the project, i.e. from September 2017 to November 2018. Time line and deliverables Confirmation of ethical approval for CODE International Survey in each country: month 6 (July 2017) Web survey of institutions ready for use: month 6 (July 2017) Fully developed, tested and web-accessible data collection tools: month 6 (July 2017) i-CODE ready for use: month 7 (Aug 2017) Completed web survey of inclusion sites: month 10 (Nov 2017) Completed international survey with at least 600 completed CODE questionnaires: month 22 (Nov 2018) Report on CODE International Survey data: month 22 (Nov 2018) SPONSORSHIP AND BUDGET Financial support for the project was granted from national research funding agencies in the participating countries, except in the UK. The University of Liverpool, UK, takes part in the project as self-financed partner. No commercial interests are involved in the study. No conflicts of interest have been declared. Participants receive no financial benefit for participation. ETHICAL APPROVAL AND GOVERNANCE The Project Lead (PI) for each country will seek the necessary approvals for CODE International Survey, from their local/regional ethics committee, and from their institutional review board as needed. All countries will need ethical approval for WP2. All potential participants will be given a Participant Information Sheet detailing the aims of the study and informing that participation is fully voluntary. PATIENT AND PUBLIC INVOLVEMENT Both volunteers and bereaved relatives will be deeply involved in developing i-CODE to be used for the international survey. After the survey has been performed, bereaved relatives will be involved in the action planning on how to address the main areas of concern identified. CONFIDENTIALITY AND DATA MANAGEMENT The Project Lead for each country will preserve the confidentiality of participants taking part in the study. All data will be anonymised and individual participants will not be identifiable from published data. All data will be stored on a secure, password protected research server. Data will be stored for up to five years after the completion of the project before being confidentially shredded or deleted. DISSEMINATION AND PUBLICATIONS A website for the project will be established. Authorship will be defined according to the Vancouver Guidelines. National data may be published by the study group in each country. The last project meeting with presentations and discussions of the project findings will be arranged as an open international conference.


Recruitment information / eligibility

Status Completed
Enrollment 914
Est. completion date December 7, 2018
Est. primary completion date December 7, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Next-of-kin to a patient who died an 'expected' death from cancer in hospital - Has been present at the hospital together with the patient at least some of the time during the patient's last two days. (This might not always be known or recorded, therefore the participant may have the option to pass the questionnaire on to somebody better placed to complete it.) - Patient was = 18 years of age at the time of Death - Patient had been admitted to the hospital (not any specific ward) at least three calendar days (e.g., admission August 1st, died August 3rd) - Able to give written informed consent, which might be implied when the participant completes and returns the questionnaire, in keeping with the ethical stipulations for each country Exclusion Criteria: - Patient had a sudden and unexpected death - Unable to complete the questionnaire due to language abilities or reduced cognitive functioning (in some countries the offer of a translator would be provided if someone wanted to complete the questionnaire but had difficulty due to languages)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Argentina Hospital Carlos B. Udaondo Buenos Aires
Argentina Instituto de Investigaciones Médicas Alfredo Lanari. Universidad de Buenos Aires Buenos Aires
Argentina Hospital Universitario Privado de Córdoba Córdoba
Brazil Sumare State Hospital São Paulo
Germany Katholisches Klinikum Mainz Mainz
Germany University Medical Centre of the Johannes Gutenberg University of Mainz Mainz
Norway Bærum Hospital, Vestre Viken Bærum
Norway Haraldsplass Deaconal Hospital Bergen
Norway Haukeland University Hospital Bergen
Norway Førde Central Hospital Førde
Norway Haugesund Hospital Haugesund
Norway Stavanger University Hospital Stavanger
Norway St Olavs Hospital Trondheim
Poland Pulmonological Hospital in Bydgoszcz Bydgoszcz
Poland D. Wladyslaw Bieganski Regional Specialist Hospital Grudziadz
Poland F. Dlutek Autonomic Public Healthcare Centre Rypin
Poland Provincial Specialist Hospital in name of the blessed priest Popieluszko Wloclawek
Poland Paluckie Health Centre, Znin Hospital Znin
United Kingdom Royal Liverpool University Hospital Liverpool
Uruguay Mutualista Asociación Hospital Evangélico Montevideo

Sponsors (7)

Lead Sponsor Collaborator
University of Bergen Mutualista Asociación Hospital Evangélico, Pallium Latinoamérica N.G.O, Sue Ryder House administered by Pallmed, University Medical Center Mainz, University of Campinas, Brazil, University of Liverpool

Countries where clinical trial is conducted

Argentina,  Brazil,  Germany,  Norway,  Poland,  United Kingdom,  Uruguay, 

References & Publications (28)

Burge F, Lawson B, Johnston G, Asada Y, McIntyre PF, Grunfeld E, Flowerdew G. Bereaved family member perceptions of patient-focused family-centred care during the last 30 days of life using a mortality follow-back survey: does location matter? BMC Palliat Care. 2014 May 14;13:25. doi: 10.1186/1472-684X-13-25. eCollection 2014. — View Citation

Department of Health (2008). End of life care strategy. Promoting high quality care for all adults at the end of life. Department of Health: London.

Department of Health (2013) The NHS Friends and Family Test: Publication Guidelines.

Gerlach C, Baus M, Gianicolo E, Bayer O, Haugen DF, Weber M, Mayland CR; ERANet-LAC CODE Core scientific group. What do bereaved relatives of cancer patients dying in hospital want to tell us? Analysis of free-text comments from the International Care of — View Citation

Germain A, Mayland CR, Jack BA. The potential therapeutic value for bereaved relatives participating in research: An exploratory study. Palliat Support Care. 2016 Oct;14(5):479-87. doi: 10.1017/S1478951515001194. Epub 2015 Oct 29. — View Citation

Goldraij G, Tripodoro VA, Aloisio M, Castro SA, Gerlach C, Mayland CR, Haugen DF; ERANet-LAC CODE Project Group; ERANet-LAC CODE project group. One chance to get it right: improving clinical handovers for better symptom control at the end of life. BMJ Ope — View Citation

Hansen MIT, Haugen DF, Sigurdardottir KR, Kvikstad A, Mayland CR, Schaufel MA; ERANet-LAC CODE project group. Factors affecting quality of end-of-life hospital care - a qualitative analysis of free text comments from the i-CODE survey in Norway. BMC Palli — View Citation

Haugen DF, Hufthammer KO, Gerlach C, Sigurdardottir K, Hansen MIT, Ting G, Tripodoro VA, Goldraij G, Yanneo EG, Leppert W, Wolszczak K, Zambon L, Passarini JN, Saad IAB, Weber M, Ellershaw J, Mayland CR; ERANet-LAC CODE Project Group. Good Quality Care fo — View Citation

Hjorth NE, Hufthammer KO, Sigurdardottir K, Tripodoro VA, Goldraij G, Kvikstad A, Haugen DF; ERANet-LAC CODE project group; Core scientific group. Hospital care for the dying patient with cancer: does an advance care planning invitation influence bereaved — View Citation

Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012 Dec;40(8):795-805. doi: 10.1177/1403494812465030. — View Citation

Mayland C, Williams E, Ellershaw J. How well do current instruments using bereaved relatives' views evaluate care for dying patients? Palliat Med. 2008 Mar;22(2):133-44. doi: 10.1177/0269216307085742. — View Citation

Mayland C. User-guide for 'Care of the Dying Evaluation' (CODETM). The Marie Curie Palliative Care Institute Liverpool, 2015.

Mayland CR, Gerlach C, Sigurdardottir K, Hansen MIT, Leppert W, Stachowiak A, Krajewska M, Garcia-Yanneo E, Tripodoro VA, Goldraij G, Weber M, Zambon L, Passarini JN, Saad IB, Ellershaw J, Haugen DF. Assessing quality of care for the dying from the bereav — View Citation

Mayland CR, Keetharuth AD, Mukuria C, Haugen DF. Validation of 'Care Of the Dying Evaluation' (CODETM) within an international study exploring bereaved relatives' perceptions about quality of care in the last days of life. J Pain Symptom Manage. 2022 Jul; — View Citation

Mayland CR, Lees C, Germain A, Jack BA, Cox TF, Mason SR, West A, Ellershaw JE. Caring for those who die at home: the use and validation of 'Care Of the Dying Evaluation' (CODE) with bereaved relatives. BMJ Support Palliat Care. 2014 Jun;4(2):167-174. doi: 10.1136/bmjspcare-2013-000596. Epub 2014 Mar 28. — View Citation

Mayland CR, Mulholland H, Gambles M, Ellershaw J, Stewart K. How well do we currently care for our dying patients in acute hospitals: the views of the bereaved relatives? BMJ Support Palliat Care. 2017 Sep;7(3):316-325. doi: 10.1136/bmjspcare-2014-000810. Epub 2017 Jan 17. — View Citation

Mayland CR, Williams EM, Addington-Hall J, Cox TF, Ellershaw JE. Assessing the quality of care for dying patients from the bereaved relatives' perspective: further validation of "Evaluating care and health outcomes--for the dying". J Pain Symptom Manage. 2014 Apr;47(4):687-96. doi: 10.1016/j.jpainsymman.2013.05.013. Epub 2013 Nov 5. — View Citation

Mayland CR, Williams EM, Addington-Hall J, Cox TF, Ellershaw JE. Does the 'Liverpool Care Pathway' facilitate an improvement in quality of care for dying cancer patients? Br J Cancer. 2013 May 28;108(10):1942-8. doi: 10.1038/bjc.2013.203. Epub 2013 May 16. — View Citation

Mayland CR, Williams EM, Ellershaw JE. Assessing quality of care for the dying: the development and initial validation of a postal self-completion questionnaire for bereaved relatives. Palliat Med. 2012 Oct;26(7):897-907. doi: 10.1177/0269216311424953. Epub 2011 Nov 1. — View Citation

National care of the dying audit for hospitals, England. National report, Royal College of Physicians, May 2014

Office of National Statistics (2014). National Survey of Bereaved People (VOICES) 2014. Office of National Statistics.

Pastrana T, De Lima L, Wenk R, et al. Atlas de Cuidados Paliativos de Latinoamérica. Houston,TX: IAHPC Press, 2012.

Pastrana T, Eisenchlas J, Centeno C, De Lima L. Status of palliative care in Latin America: looking through the Latin America Atlas of Palliative Care. Curr Opin Support Palliat Care. 2013 Dec;7(4):411-6. doi: 10.1097/SPC.0000000000000008. — View Citation

Quality Assurance for Care of the Dying: Cheshire & Merseyside Strategic Clinical Network. Network Report. October 2015.

Stiel S, Heckel M, Bussmann S, Weber M, Ostgathe C. End-of-life care research with bereaved informal caregivers--analysis of recruitment strategy and participation rate from a multi-centre validation study. BMC Palliat Care. 2015 May 2;14:21. doi: 10.1186/s12904-015-0020-4. — View Citation

The 2015 Quality of Death index. Ranking palliative care across the world. The Economist Intelligence Unit. A report by The Economist Intelligence Unit. Lien Foundation 2015.

The International Collaborative for Best Care for the Dying Person. Supporting Care in the Last Hours or Days of Life. May 2014.

van der Heide A, de Vogel-Voogt E, Visser AP, van der Rijt CC, van der Maas PJ. Dying at home or in an institution: perspectives of Dutch physicians and bereaved relatives. Support Care Cancer. 2007 Dec;15(12):1413-21. doi: 10.1007/s00520-007-0254-7. Epub 2007 Apr 20. — View Citation

* Note: There are 28 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Other Individual Items of CODE (Care Of the Dying Evaluation) Questionnaire. Individual questionnaire items of the CODE (Care Of the Dying Evaluation) questionnaire. Maximum value 4, minimum value 0. The higher score, the better outcome. 6-8 weeks post bereavement
Primary CODE (Care Of the Dying Evaluation) Questionnaire Item 30 Score for Relatives' Perception of How Much of the Time the Deceased Patient Was Treated With Dignity and Respect, by Nurses, and by Doctors CODE (Care Of the Dying Evaluation) questionnaire, item 30: How much of the time was the deceased patient treated with dignity and respect, by nurses, and by doctors.
Maximum obtainable score 4, minimum 0. The higher score, the better outcome.
6-8 weeks post bereavement
Primary Number of Participants (Relatives) Answering "Yes" to CODE (Care Of the Dying Evaluation) Questionnaire Item 31: Were You Adequately Supported in the Patients' Last Days of Life? CODE (Care Of the Dying Evaluation) questionnaire, item 31: Were you adequately supported in the patient's last days of life? Yes/no question. The higher percentage of relatives answering 'yes', the better outcome. 6-8 weeks post bereavement
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A